PACGEN LIFE SCIENCE CORPORATION

Inactive Instrument

Highlights Pacgen Life Science Corporation

Equities

PBS

CA69374M1041

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.	29/09/20	CI
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2020	31/08/20	CI
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2020	29/07/20	CI
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.	06/07/20	CI
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2019	24/02/20	CI
Pacgen Life Science Corporation Reports Earnings Results for the Second Quarter Ended September 30, 2019	28/11/19	CI
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2019	29/08/19	CI
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2019	29/07/19	CI
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2018	01/03/19	CI
Pacgen Life Science Corporation Gains Exclusive Global Commercial Rights to DermaMed, DermaSoleil and Deserving Health	12/05/17	CI
Pacgen Life Science Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	28/02/16	CI
Pacgen Life Science Corporation Enters Agreement with General Biologicals Corporation	26/01/14	CI
Pacgen Biopharmaceuticals Corporation Signs an Amendment to its License Agreement with ACI Global Corporation	30/01/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer